OSIR
Tal y como esperaba, anuncian que son incapaces de presentar el informe. Debería caer como una losa y producirme mucha pasta :D
Edito: estáis a tiempo de meterle corto. La van a echar del Nasdaq.
Osiris Therapeutics, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the period ended September 30, 2016 (the “Q3 2016 Quarterly Report”) by the prescribed due date of November 9, 2016. As previously disclosed, the Company is in the process of completing its accounting review of revenue recognition under contracts with distributors that was previously reported in its financial statements in 2014 and 2015, completing amendments to certain periodic reports previously filed with the Securities and Exchange Commission and transitioning to a new independent registered public accounting firm that will require additional time to audit the Company’s 2015 financial statements and conduct a review of the Company’s unaudited Q3 2016 financial statements. The specific date of the filing of the Q3 2016 Quarterly Report is not yet known, but the Company currently does not expect to file the Q3 2016 Quarterly Report within the extension period of five calendar days provided under Rule 12b-25 of the Securities Exchange Act of 1934, as amended.
http://files.shareholder.com/downloads/OSIR/3221519206x0xS1104659%2D16%2D156969/1360886/filing.pdf
«Después de nada, o después de todo/ supe que todo no era más que nada.»